Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.

ABSTRACT:

SUBMITTER: Ernst M 

PROVIDER: S-EPMC8436585 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature